Expert Buying Tips,vasoactive intestinal polypeptide

Vasoactive intestinal peptide (VIP), a crucial 28-amino acid polypeptide, plays a significant role in numerous physiological processes. Understanding its origins, particularly the amino acid precursors involved in its synthesis, is key to comprehending its function and potential therapeutic applications. VIP belongs to the glucagon/secretin superfamily and is widely distributed across various tissues, primarily in neural and endocrine cells. While the mature VIP peptide is composed of 28 amino acids, its journey begins with a larger precursor protein.

The synthesis of Vasoactive Intestinal Peptide originates from a precursor protein known as prepro-VIP. This precursor molecule, in humans, is a protein of approximately 170 amino acids with a molecular weight of around 19,169 Daltons. Within this prepro-VIP structure, there's a signal peptide of roughly 20 amino acids that directs the protein for secretion. Following the signal peptide, the precursor contains the sequence for VIP itself, along with other related peptides.

One of the significant components derived from the prepro-VIP precursor is peptide histidine isoleucinamide (PHI), also known as PHM due to its NH2-terminal histidine and COOH-terminal methionine amide. This 27-amino acid peptide is co-produced with VIP. Research has indicated that these precursor-derived peptides, including VIP and PHI/PHM, possess potent biological activities. For instance, vasoactive intestinal polypeptide precursors have demonstrated highly potent bronchodilatory activity, suggesting roles beyond just being simple intermediaries.

The amino acid sequence of VIP is well-characterized. While the exact sequence can vary slightly between species (e.g., porcine vs. chicken), the human form is a 28-amino acid peptide. The sequence is H-His-Ser-Asp-Ala-Val-Phe-Thr-Asp-Asn-Tyr-Thr-Arg-Leu-Arg-Lys-Gln-Met-Ala-Val-Lys-Lys-Tyr-Leu-Asn-Ser-Ile-Leu-OH. This specific arrangement of amino acids dictates its interaction with its cognate receptors, primarily the Vasoactive Intestinal Peptide receptors (VPAC1 and VPAC2). The binding to these receptors, particularly VPAC2 receptors, is crucial for its various functions, such as stimulating glucose-dependent insulin secretion.

The processing of prepro-VIP into mature VIP and other peptides involves proteolytic cleavage, a sophisticated biological mechanism that ensures the correct formation of active molecules. Studies have mapped the active site within VIP, with some research focusing on fragments derived from the C-terminus, such as Stearyl-Lys-Lys-Tyr-Leu-NH2, which is related to VIP and pituitary adenylate cyclase activating peptide (PACAP). These fragments offer insights into the functional domains of the peptide.

It is important to distinguish VIP from other related peptides. While VIP belongs to the glucagon/secretin superfamily, which also includes Glucagon-like peptide-2 (GLP-2), VIP has its unique functions. The endogenous peptide ligands in this family include PACAP, VIP, PHI/PHM and PHV.

The study of VIP's synthesis and function is an ongoing area of research. Understanding the precise amino acid composition and the processing of its precursor proteins, like prepro-VIP, is fundamental for exploring its diverse physiological roles, including its effects on the cardiovascular system, gastrointestinal function, and even its potential therapeutic applications in various conditions. The journey from a large precursor protein to a biologically active amino acid peptide highlights the intricate nature of molecular biology and the significance of each amino acid in forming complex and vital molecules.